Status:

COMPLETED

Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors

Lead Sponsor:

University Hospital, Aachen

Conditions:

Reperfusion Injury

Hypothermic Oxygenated Machine Perfusion

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Kidney transplantation (KT) has emerged as the mainstay of treatment for end-stage kidney disease. In an effort to address the widening gap between demand and supply of donor organs, there has been an...

Detailed Description

The present trial is an investigator-initiated pilot study on the effects of HOPE on ECD-allografts in DBD KT. Fifteen kidney allografts with defined inclusion/exclusion criteria will be submitted to ...

Eligibility Criteria

Inclusion

  • Dialysis-requiring Patients, suffering from end stage kidney disease, listed for KT and receiving ECD organs at the Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany. Informed consent is obtained from all subjects participating in the trial by a qualified member of the study team.
  • ECD is defined as followed: deceased donors \> 60 years and older, and those aged between 50-59 years with at least two of the following conditions: cerebrovascular cause of death, serum Creatinine greater than 1.5 mg/dL (132.6 µmol/L), history of arterial hypertension

Exclusion

  • Recipients of living donor kidney transplants
  • Previous kidney transplantation
  • Participation in other kidney related trials
  • The subject received an investigational drug within 30 days prior to inclusion
  • The subject is unwilling or unable to follow the procedures outlined in the protocol
  • The subject is mentally or legally incapacitated
  • Non-German or non-English speakers
  • Family members of the investigators or employees of the participating department
  • The subject is mentally or legally incapacitated
  • The subject suffers from uncontrolled bacterial or viral infection

Key Trial Info

Start Date :

December 5 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 30 2020

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT03378817

Start Date

December 5 2017

End Date

March 30 2020

Last Update

April 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Surgery and Transplantation, University Hospital RWTH Aachen

Aachen, Germany, 52074